INTRODUCTION
Despite remarkable progress, we are ignorant of much of the pathogenesis of the "slow virus" encephalopathies and M.S. For example, in progressive multifocal leukoencephalopathy (PML) it is thought that a papova virus attack on oligodendroglia is responsible for the impairment of myelin production. It is not known, however, what specific effector mechanism is required to prevent viral replication in the brain. Subacute sclerosing panencephalitis (SSPE) is associated with an abortive measles virus infection of the brain and a marked antibody response. What is not known are the features of the host-virus interaction which render the host defense response ineffective. In Creutzfeld-Jakob Disease (CJD) there is no evidence that the host recognizes any antigenicity in the transmissible agent. Finally, M.S. is thought by many to be a virus-induced, immune-mediated disease. Exacerbation and remission may result from fluctuation of immune regulation. However, this is not proven, nor have the reasons for the fluctuation been established.
It therefore seems appropriate to review these diseases in the context of the host immune response. The immune response will be considered as consisting of antigen recognition, effector mechanisms, and immunoregulation. In Table 1 the diseases are listed under the component of the immune response which appears crucial to the failure of the host to control the disease. This does not mean that the other components are necessarily intact. [1] . Kuru, found exclusively in New Guinea, was transmitted to subhuman primates by Gajdusek and his colleagues. It has declined markedly since the termination of ritual cannibalism. CJD, in contrast, is found in many parts of the world. Its central clinical effect is dementia with myoclonic jerks and an electroencephalographic pattern of burst suppression. The neuropathological changes consist of the spongiform change, loss of neurons, and proliferation of glia [2] .
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Although extremely high infectivity titers in infected brain can be measured by transmission to experimental animals, conventional virus has not been isolated. Furthermore, these agents are unusually resistant to many treatments that destroy infectivity of conventional agents such as nucleases, proteases, heat (800C), UV irradiation, and formaldehyde. They do, however, appear to be vulnerable to treatments which disrupt membranes [1] , suggesting that they may be closely associated with host membranes. The insensitivity to conventional inactivation techniques coupled with accidental surgical transmission in humans has led to the formulation of safety procedures for handling CJD patients [3] .
One of the most remarkable features of all the spongiform encephalopathies is the absence of any evidence of a host defense response. The brain contains no features of inflammation such as mononuclear perivascular infiltration, glial nodules, or phagocytic cells. Although the CSF protein may be mildly elevated, there is no CSF pleocytosis [4] . No evidence of serum neutralizing activity has been found, nor is there evidence of deposition of immune complexes. Furthermore, attempts to induce in vitro blastogenesis of leukocytes of diseased animals with infected material have failed [5] . Finally, it has not been possible to immunize against CNS disease in experimental scrapie infection of goats [6] . Thus, there is no evidence that antigen recognition occurs on exposure to this class of agent. Since disease does not occur in the setting of an immunocompromised host, it seems most likely that the failure of recognition relates to the agent itself. Demonstration or experimental induction of antigen recognition would be a significant contribution to the understanding of these diseases.
FAILURE OF EFFECTOR RESPONSE Generalized Immune Impairment:PML PML is a rare demyelinating disease of the central nervous system often occurring in the setting of an immunosuppressive systemic illness [7] .
The neuropathology is characterized by foci of demyelination, bizarre apparently transformed astroglia, and destruction of oligodendroglia involving enlargement, intranuclear inclusions, and lysis. Papova virus originally identified by electronmicroscopy (E.M.) [8] has been isolated from PML diseased brains [9] . It is felt that the diverse clinical symptomatology results from impairment of myelin production in papova virus-infected oligodendroglia. [22] . Furthermore, Hall et al. have shown that the mRNA coding for the matrix (M) polypeptide has a higher molecular weight in SSPE virus than in measles virus and that the respective M proteins are antigenically distinct [23] . Concurrently, Wechsler and Fields reported that the M polypeptide of five SSPE isolates migrated differently than that of the Edmonston strain of measles virus [24] . Hall et al. did not find an electrophoretic pattern characteristic of SSPE virus [25] . They did find a relative lack of antibodies to the M protein in sera from SSPE patients. The role of the M polypeptide is presumed to be in nucleocapsid and cell membrane recognition during virus maturation. The effect of the altered M polypeptide in SSPE is not known. One possibility is that it might produce a measles-infected cell which is not susceptible to cytotoxic effector mechanisms of the host.
One of the major problems in understanding the pathogenesis of SSPE is the repeated demonstration of antiviral effector function in patients. Specific humoral immune function is demonstrated by high levels of circulating and locally produced antibody [18] . The presence of cell-mediated cytotoxicity against measles-infected targets has been demonstrated in vitro [26, 27, 28] . How then does the virus survive in the face of specific effector capability? At present there are at least three mechanisms resulting from virus host cell interaction to explain the failure of host effector mechanisms. First, circulating and CSF factors that block immune responses, possibly immune complexes, have been described [29] . Second, the proposal has been made by Oldstone and his colleagues that antibody strips viral antigen from infected cells, resulting in an antigenically modulated target no longer susceptible to cytotoxicity. That group has recently shown that surface antibody can also alter the production of viral protein within the cell [30] . Finally, an altered M polypeptide might result in a measles-infected cell no longer recognized by host cytotoxic effector mechanisms. The relative lack of antibodies to the M polypeptide in SSPE supports this concept [25] .
The remarkable clinical pattern of SSPE, initial infection and resolution followed years later by a relentlessly progressive panencephalitis, also occurs in progressive rubella panencephalitis (PRP). Although incompletely characterized because of the paucity of reported cases, PRP has not been associated with a generalized defect of humoral or cell-mediated immunity [31] . The onset at the start of the second decade follows congenital or childhood rubella and progresses relentlessly over a few years with dementia and ataxia as principal features. Cerebellar atrophy, white matter destruction, perivascular infiltration, neuronal loss, gliosis, and amorphous vascular deposits characterize the neuropathology [32] . Rubella virus has been isolated from the brain and locally produced anti rubella antibody is found in the CSF [33] . The CSF IgG is elevated and oligoclonal bands containing anti rubella antibody are found [34] . Thus, PRP is an illness in which viral antigens are recognized and a specific immune response produced. However, like SSPE, interaction of the virus and the host apparently allows the establishment of latency and, years later, the emergence of a destructive CNS disease. [43] .
Our own pilot studies [44] CONCLUSION Although the diseases have been discussed as reflecting types of failure of the host immune response, it is not anticipated that these defects will turn out to be isolated. Thus, it is entirely possible that defects of more than one type will be found in any given disease. It is hoped, however, that this analysis will generate experimental questions about the pathogenesis of the diseases.
